Literature DB >> 15746491

Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus.

Robert Paul1, Timothy P Flanigan, Karen Tashima, Ronald Cohen, Jay Lawrence, Elizabeth Alt, David Tate, Corrine Ritchie, Charles Hinkin.   

Abstract

Apathy is a prominent neuropsychiatric symptom associated with human immunodeficiency virus (HIV). The increased frequency of apathy in this population may reflect the direct involvement of the virus on the central nervous system (CNS), but the severity of apathy has not been shown to consistently relate to markers of disease activity or other neuropsychiatric complications of the virus. We examined the relationship between ratings of apathy and performance on measures of cognitive function and immune system status in a sample of HIV-infected patients. Apathy was significantly elevated among HIV-infected individuals compared to healthy comparison subjects. Apathy was significantly related to performance on measures of learning efficiency and a measure of cognitive flexibility. Ratings of apathy did not relate to CD4 cell count, but they were associated with disease duration. In addition, ratings of depression were independent of ratings of apathy. These findings suggest that apathy does not co-vary with a proxy measure of active disease status, but apathy does relate to several measures of cognitive dysfunction in patients with HIV. As such, the increased prevalence of apathy among HIV-infected adults may reflect HIV-associated neurologic dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 15746491     DOI: 10.1176/jnp.17.1.114

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  23 in total

1.  Behavioral and neuroimaging evidence for impaired executive function in "cognitively normal" older HIV-infected adults.

Authors:  Xiong Jiang; Rebecca Barasky; Halli Olsen; Maximilian Riesenhuber; Manya Magnus
Journal:  AIDS Care       Date:  2015-11-17

2.  Apathy is associated with lower mental and physical quality of life in persons infected with HIV.

Authors:  Rujvi Kamat; Steven Paul Woods; Marizela V Cameron; Jennifer E Iudicello
Journal:  Psychol Health Med       Date:  2016-01-19       Impact factor: 2.423

3.  Cognitive reserve protects against apathy in individuals with human immunodeficiency virus.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Deena Peyser; Barry S Zingman; Joe Verghese
Journal:  Arch Clin Neuropsychol       Date:  2013-09-09       Impact factor: 2.813

Review 4.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Implications of apathy for everyday functioning outcomes in persons living with HIV infection.

Authors:  Rujvi Kamat; Steven Paul Woods; Thomas D Marcotte; Ronald J Ellis; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-06-15       Impact factor: 2.813

6.  Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.

Authors:  Vaughn E Bryant; Nicole E Whitehead; Larry E Burrell; Vonetta M Dotson; Robert L Cook; Paul Malloy; Kathryn Devlin; Ronald A Cohen
Journal:  AIDS Behav       Date:  2015-08

7.  Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Barry S Zingman; David L Pogge; Joe Verghese
Journal:  J Clin Exp Neuropsychol       Date:  2013-10-04       Impact factor: 2.475

8.  Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil.

Authors:  Rujvi Kamat; Erin Morgan; Thomas D Marcotte; Jayraan Badiee; Ingrid Maich; Mariana Cherner; Sergio de Almeida; Ana Paula de Pereira; Clea Elisa Ribeiro; Francisco Barbosa; J Hamp Atkinson; Ronald Ellis
Journal:  J Affect Disord       Date:  2012-12-11       Impact factor: 4.839

9.  Neurocognitive deficits in HIV-positive patients-two case reports: Revising current AANTF guidelines in view of recent revelation of new neurocognitive symptoms.

Authors:  V N Vahia; Tejas Bhojraj; Dean A Creado
Journal:  Indian J Psychiatry       Date:  2006-07       Impact factor: 1.759

10.  Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

Authors:  Robert Paul; Gina Rhee; Laurie M Baker; Florin Vaida; Sarah A Cooley; Beau M Ances
Journal:  J Neurovirol       Date:  2017-09-11       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.